Want to join the conversation?
New York-based biopharmaceutical firm $BMY posted 4Q15 net loss attributable to the company of $138MM or $0.08 per share, hurt by higher expenses. This compared to net earnings of $13MM or $0.01 per share in 4Q14. Revenue of $4.3Bil grew 1% compared to last year. Non-GAAP net earnings attributable to $BMY were $647MM or $0.38 per share in 4Q15.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.